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Abstract 
Peripheral arterial disease (PAD) is a manifestation of systemic atherosclerosis 
which causes significant morbidity and mortality affecting between 14% and 29% of 
individuals >70 years of age.  Multiple studies have demonstrated an improvement in 
walking distance in people suffering from symptomatic PAD through exercise 
therapy. While most studies have examined the results of exercise and risk factor 
modification programs over a short-term  this study sought to identify not only 
whether a nurse-led intervention program can improve functional capacity and 
quality of life, but if improvements could be sustained over a longer follow-up term.  
There were 56 participants recruited from the Vascular Surgery Outpatients 
department at the Princess Alexandra Hospital, Brisbane. The nurse-led intervention 
program consisted of a 12-week supervised exercise program as well as a home 
walking prescription and fortnightly risk factor education sessions. A further 23 
individuals who were unable to attend the intervention program due to geographical 
location agreed to complete quality of life-only follow-up and were given home 
exercise advice. 
As predicted, participants in the nurse-led intervention program (NLIP) group 
demonstrated a statistically significant improvement in both functional capacity 
(p<.01) and all domains of a PAD specific quality of life questionnaire (Vascuqol) 
except social, directly following the program (p<.05). 
Both treadmill assessment (claudication pain time and maximum walk time) and 
corridor walking assessment (6 minute walk) results continued to be significantly 
improved 12 months following the intervention program (p<.05) and at 30 months 
following intervention, claudication pain time remained significantly improved 
(p=.045). 
Participants in the NLIP group also continued to have significantly improved quality 
of life in the domains of PAD symptoms and emotion. The quality of life only (QOLO) 
group demonstrated an improvement in the domain of pain at 12 months, however 
no further improvement was evident at either 12 or 30 months. 
 After a mean follow up time of 52 months, the NLIP group had sustained a 14% 
mortality rate. This is in keeping with the 5-year predicted mortality found amongst 
PAD sufferers. 
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The results from this study suggest that a nurse-led intervention program for people 
with PAD can have sustained improvement in pain free walking distance and 
emotional well-being. Further research is required to identify whether earlier 
intervention may lead to a reduction in mortality rates in PAD population.  
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Chapter 1 
Introduction/Background 
 
1.1   Peripheral Arterial Disease 
Peripheral arterial disease (PAD) is a manifestation of systemic atherosclerosis 
which causes significant morbidity and mortality. It is defined by “atherosclerotic 
obstruction of the abdominal aorta and/or arteries to the legs that reduces arterial 
flow during exercise and/or rest” (Chi & Jaff, 2008).  
Epidemiology 
The prevalence of PAD in men and women ≥40 years of age is believed to be 
approximately 4% (Selvin & Erlinger, 2004). However, with increasing age the 
prevalence sharply increases to between 14% and 29% of individuals >70 years of 
age (Hirsch et al., 2001; Selvin & Erlinger, 2004). The pivotal Framingham Heart 
study reported a higher prevalence of PAD in men than in women (3.6%-men, 1.8%-
women) (Kannel, Skinner, Schwartz, & Shurtleff, 1970). This gender-based 
difference has also been found in multiple subsequent studies including the Quebec 
Cardiovascular Study (Dagenais, Maurice, Robitaille, Gingras, & Lupien, 1991) and 
the Cardiovascular Health study (Newman et al., 1993).   
 The Australian Institute of Health and Welfare state that no national data exists to 
identify the exact prevalence of PAD in Australia, however they do note that PAD 
was responsible for over 25,000 hospitalisation in 2006-2007 and 2,163 deaths in 
2006 (Australian Institute of Health and Welfare, 2010).  
 
Associated Cardiovascular risk   
It is the systemic nature of the atherosclerotic disease process which increases 
cardiovascular morbidity and mortality rates in people with PAD (Diehm et al., 2009). 
Within one year of presentation, 25% of patients with critical limb ischemia (CLI), the 
most advanced form of PAD die of cardiovascular causes and a further 25% suffer 
major limb amputation. Even individuals with stable or no symptoms of PAD have a 
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20% incidence of myocardial infarction or stroke and 15% to 30% mortality in 5 years 
of presentation (Figure 1)(Weitz et al., 1996).   
 
Figure 1 Reproduced with permission (Weitz et al., 1996) 
 
 Risk Factors for PAD 
Risk factors for PAD can be defined as being either modifiable, or non-modifiable as 
outlined below.  
Non-modifiable risk factors 
Genetics 
Family history has been shown to be a major determinant of risk for PAD (Valentine 
et al., 2004). Valentine, Guerra and Stephen et al found that 64% of people with a 
first degree relative with early-onset PAD (<50 years old) have documented arterial 
disease as determined by duplex ultrasound (Valentine et al., 2004). They were not 
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able to establish causality of this finding, however they were able to determine that 
family history was a major determinant of risk independent of smoking and when the 
two were combined, risk accelerated dramatically (Valentine et al., 2004).  
Genetic defects in homocysteine metabolism resulting in hyperhomocysteinemia is 
also an independent risk for PAD and increases the risk of death from cardiovascular 
disease (Graham et al., 1997). Although reduction in serum homocysteine levels can 
be achieved quite simply through dietary supplements and vitamins, there is little 
evidence to suggest that this will produce a beneficial effect in people with PAD (Chi 
& Jaff, 2008).  
Ethnicity 
In the San Diego population study (2005) black ethnicity was shown to be a strong 
risk factor for PAD, even when adjusted for higher incidence of diabetes, 
hypertension and body mass index (Criqui et al., 2005). In Australia, there is also 
great disparity between the incidence of PAD in indigenous Australians and those of 
an Anglo-Celt heritage, with indigenous Australians being almost twice as likely to 
develop PAD (Davis et al., 2012).  Results from the recent Fremantle Diabetes study 
show people of Indigenous background have not only a higher incidence of diabetes, 
but they are also diagnosed at a younger age and demonstrate poorer glycemic 
control (Davis et al., 2012). Overall, people of Indigenous background have an 18 
year shorter life expectancy than their Anglo-Celt counterparts (Davis, McAullay, 
Davis, & Bruce, 2007).      
 
Modifiable Risk Factors 
Cigarette smoking 
Cigarette smoking is the single most important modifiable risk factor for the 
development and advancement of PAD (Agarwal, 2009) (Willigendael et al., 2004). A 
2004 meta-analysis of 17 studies found a 2.2-fold greater prevalence of symptomatic 
PAD in smokers compared with non-smokers (Willigendael et al., 2004). The 
incidence of symptomatic PAD has been shown to be directly proportional to the 
dose of exposure to nicotine, with an increase from 2.6% in never smokers to 9.8% 
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in heavy smokers (Price et al., 1999).  Even passive tobacco exposure almost 
doubles the risk of development of PAD in non-smokers (He et al., 2008). The 
atherogenic effect of tobacco use has been linked to multiple eitiologies, such as 
“activation of sympathetic system resulting in vasoconstriction, oxidation of low-
density lipoprotein (LDL) cholesterol, inhibition of tissue plasminogen activator 
release from the endothelium, increased fibrinogen concentration, increased platelet 
activity, and increased expression of plaque tissue and endothelial dysfunction” (Chi 
& Jaff, 2008).  
Hyperlipidemia 
Hyperlipidemia initiates atherosclerosis by disturbing the normal homeostatic 
function of the endothelium and vascular wall (Kinlay, Libby, & Ganz, 2001). People 
with PAD tend to have a pattern of dislipidemia similar to those with metabolic 
syndrome including low high-density lipoprotein (HDL) levels and elevated 
triglyceride levels (Chi & Jaff, 2008). According to the PARTNERS (PAD Awareness, 
Risk and Treatment: New Resources for Survival) Program, the incidence of 
hyperlipidemia in PAD patients was as high as 77% (Hirsch et al., 2001).  It has been 
shown to increase the likelihood of developing PAD by 10% for every 0.259mmol/L 
rise in total cholesterol (Hiatt, Hoag, & Hamman, 1995).  
Hypertension 
Hypertension (HTN) is another prominent risk factor for PAD and is present in as 
many around 55% of people with PAD (Lane & Lip, 2009).  Atheromatous renal 
artery stenosis is a common primary cause of hypertension in people with PAD 
(Missouris, Buckenham, Cappuccio, & MacGregor, 1994). Other secondary causes 
of hypertension include endocrine disorders, such as primary hyperaldosteronism 
and diabetes mellitus (Beckman, Creager, & Libby, 2002). 
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Diabetes mellitus 
The prevalence of PAD in people with diabetes mellitus (DM) has been estimated to 
be 20% to 30% greater than in any other matched population (Marso & Hiatt, 2006). 
DM increases the risk of complications to PAD sufferers through both microvascular 
and macrovascular dysfunction. “The metabolic abnormalities associated with 
hyperglycemia and insulin resistance alter endothelial function, smooth muscle 
vasomotor balance, and platelet aggregation, thereby promoting atherosclerosis and 
thrombus formation”(Gandhi, Weinberg, Margey, & Jaff, 2011). Macrovascular 
complications include coronary artery disease, hypertension, stroke, sensory, motor 
and autonomic neuropathy, wounds, infection, and gangrene of the lower/upper 
extremities and sexual dysfunction. Microvascular complications include damage to 
arterial supply of the eyes, leading to blindness/retina disease, and also the kidneys, 
which can lead to renal failure and even dialysis (Gibbons & Shaw, 2012).  
DM alters the distribution of the disease, and PAD in diabetic patients more often 
involves the arteries below the knee than in non-diabetic patients (Dosluoglu, Lall, 
Nader, Harris, & Dryjski, 2010). PAD is more commonly asymptomatic in diabetic 
patients because of the high association of sensory and autonomic neuropathy 
(Gibbons & Shaw, 2012).  These patients are also more likely to present with tissue 
loss and are at higher risk for amputation (Jude, Oyibo, Chalmers, & Boulton, 2001). 
Due to the advanced presentation and diffuse disease often seen in diabetic 
patients, they also demonstrate reduced primary patency after endovascular 
interventions (DeRubertis et al., 2008). 
 
1.3   Presentation and Diagnosis of PAD 
Physical assessment 
PAD is often underdiagnosed and undertreated (A. Simmons, Steffen, & Sanders, 
2012). Intermittent claudication is the mildest symptomatic manifestation of PAD 
(Lauret et al., 2012). “Claudication is a word derived from the Latin word claudicato, 
meaning to limp” (Olin & Sealove, 2010). The discomfort which results is caused by 
reversible muscle ischemia. In people without PAD, exercise causes vasodilation, in 
order to deliver the higher volume of blood flow required by the muscles being used. 
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In patients with PAD exercise creates the same demand however the atherosclerotic 
narrowing limits the amount of blood and thereby oxygen which can be delivered to 
the periphery of the buttocks and/or lower extremities. This lack of oxygen causes an 
anaerobic state in which lactic acid and other metabolites are formed. This results in 
cramping or aching pain experienced one level distal to level of obstruction (eg, 
superficial femoral or popliteal obstruction causes calf pain and aortoiliac disease 
causes thigh, hip or buttock pain). In the resting state, the oxygen debt can be 
redeemed and symptoms are relieved (Olin & Sealove, 2010).  
Approximately 50% of individuals with PAD however are asymptomatic (Steffen, 
Duprez, Boucher, Ershow, & Hirsh, 2008) and symptoms similar to intermittent 
claudication can be present in patients with musculoskeletal conditions which 
highlights the need for primary care screening of at-risk patients. One of the most 
accessible ways of screening for PAD in the primary care setting is ankle-brachial 
index (ABI) testing. This simple, inexpensive and non-invasive method of 
assessment can be helpful in the diagnosis of both symptomatic and asymptomatic 
PAD.  ABI is measured using a continuous wave Doppler ultrasound device and a 
sphygmomanometer. The higher systolic pressure measured from either the 
posterior tibial or dorsalis pedis artery (in each leg) is then divided by the higher 
brachial artery pressure taken from either arm (figure 2). PAD can be diagnosed if 
ABI≤0.90 (Olin et al., 2011). ABI can produce a falsely normal result in people with 
diabetes due to poorly compressible, calcified arteries(Arain & Cooper, 2008). If the 
ABI is greater than 1.30 then the ABI should be considered indeterminate and a 
normal ABI in a symptomatic diabetic should be treated as potentially inaccurate 
(Suominen, Rantanen, Venermo, Saarinen, & Salenius, 2008). In these cases further 
investigations such as duplex ultrasound can provide a more accurate diagnosis. 
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Figure 2- Reproduced with permission from (Hiatt, 2001) Copyright Massachusetts 
Medical Society 
The Inter-Society Consensus for the Management of Peripheral Arterial Disease 
(TASC II) guidelines recommends ABI should be measured in: 
 All patients who have exertional leg symptoms. 
 All patients between the age of 50-69 and who have a cardiovascular risk 
factor (particularly diabetes or smoking). 
 All patients ≥70 years regardless of risk factor status 
 All patients with a Framingham risk score 10%-20%. (Norgren et al., 2007) 
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Functional Assessment 
As one of the more limiting features of PAD is the reduction in functional capacity 
and this can greatly affect a person’s ability to carry out their activities of daily living, 
it is important to have a quantifiable mode of assessing function capacity. 
Treadmill testing is an established means to quantify walking ability in persons with 
PAD and is highly predictive of long-term morbidity and mortality out-comes (de 
Liefde et al., 2009). It is traditionally used to measure changes in walking 
performance following therapeutic interventions among PAD sufferers. It has been 
suggested however that the degree to which treadmill testing reflects functional 
capability in daily life is uncertain (McDermott et al., 2008). Treadmill testing is 
performed according to a set protocol which specifies walking speed and gradient 
and therefore may represent a relatively artificial measure of walking ability. Corridor-
based functional performance measures such as the six-minute-walk are an 
important complement to treadmill assessment as they correlate better with physical 
activity during daily life, and studies of functional performance in persons with PAD 
should include both (McDermott et al., 2008).  
 
Quality of life assessment 
Chronic illness is the primary contributor to depression in the elderly (Pratt, Norris, & 
Kaufmann, 2005). The reduction in physical capacity in PAD can lead to a loss of 
independence and reliance upon others to perform everyday tasks. This may result 
in frustration or low self-esteem and in order to reduce what they see as burden 
upon others, people with PAD may withdraw from social activity leading to a 
reduction in their quality of life (Pratt et al., 2005). While treadmill and corridor walk 
testing are able to provide information regarding people with PAD’s  walking ability, 
they do not address their perception of his or her walking ability or health related 
quality of life (HRQOL). In assessing the efficacy of an intervention for PAD it is 
important to not only investigate improvements in functional capacity but also note if 
the improvements correlate to an improvement in quality of life.  The best way to 
assess mental health, emotional well-being, and social functioning, is through the 
use of specific questionnaires (Mays et al., 2011).  
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1.4    Treatment guidelines for PAD 
Once a diagnosis of PAD has been made, appropriate treatment must address both 
the specific lower-extremity disability and the systemic impact of the disease 
(Norgren et al., 2007). 
Both The current American College of Cardiology (ACC)/American Heart Association 
(AHA)  and TASC II guidelines recommend aggressive management of 
atherosclerotic risk factors to reduce future cardiovascular events in all patients with 
PAD (Hirsch et al., 2006) (Norgren et al., 2007). Risk factor management includes 
cessation of smoking, control of diabetes, hypertension, and hypercholesterolemia, 
along with dietary restrictions aimed at reducing low-density lipoprotein cholesterol 
and obesity (Table 1). In addition, treatment options for PAD are geared towards 
medical therapy which includes antiplatelet agents such as aspirin and clopidogrel, 
exercise rehabilitation, surgical therapy such as endovascular interventions, or 
surgical bypass. It is recommended that management of patients through medication 
and exercise should be attempted prior to the more aggressive approaches of 
endovascular intervention or surgical bypass (Gardner & Afaq, 2008).   
Table 1- ACC/AHA guidelines for cardiovascular risk factor reductions in patients 
with PAD 
                                             Recommendations 
Smoking cessation              
                                             
Quit smoking      
Weight reduction                   Counselling to reduce weight if BMI >25 
Diabetes    HBA1C goal of <7% or as close to 6% as possible         
Hyperlipidemia LDL <2.59mmol/L for all patients and <1.81mmol/L in 
patients with PAD and disease in other vascular beds  
Antiplatelet therapy               Aspirin for all patients with symptomatic PAD.  
Clopidogrel may be an effective alternative to                                  
aspirin.                 
Hypertension BP <140/90 or <130/80 in patients with diabetes mellitus 
or renal failure                                                                       
Hirsch et al (Hirsch et al., 2006) 
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Exercise therapy for PAD 
Exercise therapy has historically been prescribed for patients with intermittent 
claudication. In 1898, Wilhelm Erb a German neurologist described the successful 
results of exercise therapy for a patient with IC (Erb, 1898). More recently, in a 2008 
Cochrane review of 22 trials involving exercise for intermittent claudication, the 
authors noted that compared with usual care or placebo, exercise significantly 
improved maximal walking time with improvements ranging from 50% to 200% (C. J. 
Watson, Ellis, & Leng, 2008). Both pain-free walking distance and maximum walking 
distance also improved significantly, with pain-free walking distance increasing by a 
mean of 82.19 metres (95% CI 71.73 to 92.65) and maximum walking distance 
increasing by a mean of 113.20 metres (95% CI 94.96 to 131.43) (C. J. Watson et 
al., 2008).   
The exact mechanism by which this improvement occurs is yet to be proven 
conclusively. “There is inadequate evidence to attribute the functional benefit from 
exercise, as is often believed, to the growth of new arterial collaterals 
(angiogenesis); in contrast, clinical improvement is more likely to be due to 
alterations in skeletal muscle metabolism, muscle hypertrophy, improvements in 
endothelial function, improved cellular or subcellular function, or altered gait” (Gandhi 
et al., 2011).  
ACC/AHA guidelines recommend a supervised exercise-training program as the 
initial treatment modality for patients with intermittent claudication. Supervised 
exercise programs have in fact been shown to be as effective as endovascular 
revascularisation in their effectiveness to improve functional capacity and do so at a 
much lower cost (Spronk et al., 2008). It is also recommended that the training 
program should be performed for a minimum of 30-45mins, in sessions performed at 
least three times per week for a minimum of 12 weeks (Hirsch et al., 2006). These 
recommendations have been made based upon evidence derived from randomised 
controlled trials which have shown supervised exercise programs to be superior to 
home-based exercise programs (see table 2) (Hirsch et al., 2006). It should be noted 
however that the trials cited in the 2005 ACC/AHA guidelines are from a range of 
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years, beginning with Larsen et al in 1966. The most recent trial cited, was Petersen 
et al in 1997. All of the trials were of relatively small sample size (n=7-25) and 
questionnaires were the only tool used to assess community-based functional 
capacity. Even though there have been multiple other trials and meta-analyses since 
(Degischer et al., 2002; Gardner, Katzel, Sorkin, & Goldberg, 2002; Lee et al., 2007; 
C. J. Watson et al., 2008), the 2011 update to the ACC/AHA guidelines again refer to 
the evidence cited in the 2005 guidelines.  
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Table 2 (Hirsch et al., 2006) 
 
First Author 
 
Year 
No. of 
Patients 
 
Intervention 
Duration, 
Months 
Change in 
ACD (%) 
Functional 
Assessment* 
Larsen 
    Treatment Group 
    Control Group 
1966  
7 
7 
 
Daily Walks 
Placebo Tablet 
6  
183ˠ≠ 
-6 
None 
Holm 
    Treatment Group 
    Control Group 
1973  
6 
6 
 
Exercise 
Placebo Tablet 
4  
133ˠ≠ 
0 
None 
Dahllof 
    Treatment Group 
    Control Group 
1974  
11 
 
 
Exercise 
Placebo Tablet 
6  
117ˠ≠ 
0 
None 
Dahllof 
    Treatment Group 
    Control Group 
1976  
8 
10 
 
Exercise 
Placebo Tablet 
4 
 
 
135ˠ≠ 
75ˠ 
None 
Lundgren 
    Treatment Group1 
    Treatment Group 2 
    Treatment Group 3 
1989  
25 
25 
25 
 
Surgery + Exercise 
Surgery 
Exercise 
6  
263ˠ≠ 
173ˠ≠ 
151ˠ≠ 
None 
Creasy 
    Treatment Group 1 
    Treatment Group 2 
1990  
13 
20 
 
Exercise 
Angioplasty 
6  
442ˠ≠ 
57 
None 
 
Hiatt 
    Treatment Group 
    Control Group 
1990  
9 
10 
 
Supervised exercise 
Control 
3  
123ˠ≠ 
20 
 
Improved 
No Change 
Mannarino 
    Treatment Group1 
    Treatment Group 2 
    Treatment Group 3 
1991  
10 
10 
10 
 
Exercise + Antiplatelet 
Exercise 
Antiplatelet 
6  
105ˠ≠ 
86ˠ≠ 
38ˠ 
None 
Hiatt 
    Treatment Group 1 
    Treatment Group 2 
    Control 
1994  
9 
8 
10 
 
Supervised exercise 
Strength Training 
Control 
3  
74ˠ≠ 
36ˠ 
-1 
 
Improved 
No Change 
No Change 
Regensteiner 
    Treatment Group 1 
    Treatment Group 2 
1997  
10 
10 
 
Supervised exercise 
Home exercise 
3  
137ˠ≠ 
5 
 
Improved 
No Change 
Patterson 
    Treatment Group 1 
    Treatment Group 2 
1997  
19 
19 
 
Supervised exercise 
Home exercise 
6  
195ˠ≠ 
83ˠ 
 
Improved 
Improved 
ACD- Ambulatory claudication Distance *Use of questionnaire to evaluate community-based functional status 
ˠ p less than 0.05 compared with baseline; ≠ p less than 0.05 for difference between groups 
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1.5   The increasing cost of PAD 
Atherothrombotic disease, which encompasses coronary artery disease, ischemic 
stroke and PAD, is the most common cause of morbidity and mortality worldwide and 
as such carries great economic burden (Ademi et al., 2010) (Watkins, 2004). In 2004 
the total direct health costs in Australia for peripheral vascular disease was $240m, 
$162m of which can be attributed to in-patient Hospital  services in both the public 
and private sector (National Heart Foundation Australia, 2005). In the United States, 
census data for the same year estimated total annual costs associated with vascular-
related hospitalisations to be in excess of $21 billion (Mahoney et al., 2008). The 
international REACH (Reduction of Atherothrombosis for Continued Health) registry 
was designed to obtain long-term follow-up information on participants having or at 
high risk for atherothrombosis. Between December 2003 and June 2004, a total of 
67,888 participants were recruited from 44 countries including 2873 participants from 
Australia (Ohman et al., 2006).  Based upon the findings of this registry in 2010 
Mahoney et al (on behalf of the REACH registry investigators) concluded that 
prospective studies of the effectiveness and cost-effectiveness of secondary 
prevention strategies aimed specifically at reducing PAD-related events seem 
warranted because effective interventions may curb the otherwise impending clinical 
and economic burden of PAD in the aging population (Mahoney et al., 2008).  
   
1.6    Rationale 
It has been documented, that primary care physicians have been less diligent in 
treating atherosclerotic risk factors in patients with PAD than in patients with other 
manifestations of atherosclerosis. In 2008 Welten et al found that patients with PAD 
are indeed at increased risk for long-term mortality when compared with a risk factor 
matched population of coronary artery disease (CAD) patients primarily due to PAD 
patients receiving lass cardiovascular medical therapy including beta-blockers, 
statins, ACE inhibitors, calcium antagonists, nitrates and aspirin than CAD patients 
(Welten et al., 2008). The above mentioned ACC/AHA guidelines on exercise 
therapy can also prove difficult to translate into practice in an acute clinical setting. 
The availability of gymnasium space and appropriately trained staff to supervise 
three times a week is challenging from an institutional perspective, and for patients, 
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commuting to hospital frequently can incur great transportation costs.  This results in 
supervised exercise programs being underused or unavailable to most PAD patients 
(Gandhi, Weinberg, Margey, & Jaff, 2011).  
The key to improving long term management of people with PAD may lie in the 
creation of nurse-led intervention programs. This involves the appointment of an 
appropriately trained nurse who not only develops a rapport with patients, but is then 
able to co-ordinate the multidisciplinary team to ensure PAD patients are provided 
the risk factor modification, supervised exercise and education necessary for both 
the short and long term management of their chronic disease.  
1.7      Aim/Hypothesis 
While there is sufficient evidence to demonstrate functional improvement directly 
following the completion of a vascular exercise program, there is a paucity of 
evidence relating to the sustainability of this improvement. The following literature 
review will explore the evidence relating to current programs for PAD which are more 
commonly coordinated from within an exercise or physiotherapy discipline and 
identify how nurse-led programs may provide a more holistic approach. It will also 
examine the evidence base behind nurse-led intervention programs for other 
conditions and how their introduction has shaped both patient care and outcomes. 
The aim of the research contained in this thesis is to identify if a nurse-led 
intervention program for patients with peripheral arterial disease can demonstrate a 
sustained improvement in functional capacity and quality of life 12 months following 
a 12-week program. This evidence has the potential to significantly contribute to the 
evidence base required for ongoing funding of such programs to allow for more 
effective care and improved outcomes for people with PAD. 
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Chapter 2 
Literature Review 
 
2.1   Nurse-led intervention programs 
Within aging populations, there is mounting pressure to find cost-effective ways to 
manage increasing numbers of individuals with chronic illness who are frequently 
hospitalised (Dai, Wu, & Weng, 2002; Pearson et al., 2006; Stewart, MacIntyre, et 
al., 2001).  A wide range of nurse-led multidisciplinary programs have been 
developed to manage chronic diseases and provide continuity of care from the 
hospital to home. It has been proven that these nurse-led programs improve disease 
management, (Weingarten et al., 2002) reduce mortality, (Elkan et al., 2001) and 
decrease recurrent hospitalisation rates (Stewart, Pearson, Luke, & Horowitz, 1998).  
In 2012, the Australian Medicare Local Alliance defined nurse-led care as;  
 ‘patient care that is primarily coordinated by nursing staff with support from 
the general practice team. Nurse-led care in this context includes, but is not limited 
to, health education, promotion and disease prevention, and psychological support 
such as listening to and discussing patients’ concerns. It also includes the provision 
of clinical care and monitoring patients’ health conditions. The level of care provided 
varies and is determined by the scope of practice of each nurse.’ (Australian 
Medicare Local Alliance, 2012) 
 
The primary care setting has been one of the leading fields in the development of 
nurse-led care and the above definition and document from which it has been 
sourced, is a significant advancement in outlining the role of, and providing a 
framework of care, for general practice nurses in Australia. While the role of the 
practice nurse (PN) has been well defined and utilised in the United Kingdom since 
the 1990’s, Australia has lagged behind due to multiple factors which will be 
discussed in greater detail in the following section (Hoare, Mills, & Francis, 2012).  
2.2     Nurse-led interventions in Primary Care 
The earliest publication regarding the use of practice nurses was in 1967 in which 
two British doctors in general practice employed a nurse to triage calls, provide first 
visits, immunise, and routinely visit elderly patients (Smith & Mottram, 1967). After 
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further studies in 1969 and 1974 highlighted the potential gain of employing practice 
nurses, more general practitioners (GPs) began to do so (Dixon, 1969; Reedy, 
Philips, & Newell, 1976). In the early 1990’s in the UK, following the development of 
a contract arising from the National Health System and Community Care Act (OPSI, 
1990) and the Health of the Nation White Paper (Department of Health, 1992), GPs 
received payment for introducing services to provide health promotion, manage 
chronic disease and additional payments for childhood immunisation and cervical 
smear tests . These financial incentives led to greater expansion of the practice team 
as GPs employed more practice nurses to reach these targets (Gemmell, Campbell, 
Hann, & Sibbald, 2009). The election of the Labour Government in 1997 led to 
further developments which would accelerate the use of nurse-led care. This 
included the creation of Primary Care Groups which brought together GPs, practice 
nurses, community nurses and other primary care professionals to increase clinical 
leadership, and the creation of a quality improvement system, clinical governance 
(Allen, 2000). Clinical governance was a novel initiative which provided a system of 
accountability for the delivery of quality care as all previous government reporting 
had been strictly financially based (Hoare et al., 2012). This system evolved into the 
Quality and Outcome Framework (QOF) which uniquely assessed GP clinics 
according to five domains; clinical, organisational, patient experience, additional 
services and access. GP clinics were awarded points for their achievements in each 
domain which greatly increased the government funding provided to the clinic 
(Ashworth, Seed, Armstrong, Durbaba, & Jones, 2007).  
Following the introduction of the quality framework nurses were found to be 
absorbing more of the workload than GPs, however nurses believed patients to be 
receiving improved continuity of care (Gemmell et al., 2009; McGregor, Jabareen, 
O'Donnell, Mercer, & Watt, 2008). Practice nurses also identified that the increased 
level of autonomy improved their sense of job satisfaction (Maisey et al., 2008). 
In Australia, although facing similar issues with growing numbers of individuals with 
chronic disease, the extension of the practice nurse role is still an emerging specialty 
when compared to the United Kingdom (UK) (Halcomb, Davidson, Griffiths, & Daly, 
2008). One of the major issues causing this delay may be the different government 
funding practices. In the UK government funding is provided to GP clinics based 
upon capitation of enrolled patients along with incentive programs for quality of care 
as previously described (Hoare et al., 2012). In Australia, general practice is 
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predominantly self-employed medical practitioners who receive government funding 
on a ‘fee-for-service’ basis from Medicare. The Australian system has been 
described as ‘complex’ as around 85% of the scheduled fee is covered by Medicare 
and then individual practices determine whether or not the consumer will pay an 
additional fee (Halcomb, Davidson, & Patterson, 2008). Between 2004 and 2007 the 
Australian Government approved eight new item numbers under the Medical 
Benefits Schedule (MBS) for remuneration of certain services provided by a practice 
nurse including immunisation and cervical screening (Keleher et al., 2007). The 
number of nurses working in general practice during this period of time increased by 
23% presumably in response to this initiative (Australian General Practice Network, 
2007). However, a study by Mills and Fitzgerald (2008) identified some key obstacles 
practice nurses encountered in implementing these services (Mills & Fitzgerald, 
2008). Their action research study involved the creation of a small reflective group of 
practice nurses who were credentialed to complete cervical screening. They 
identified that the nurses frequently encountered problems due to the fact that the 
GPs were not only their colleagues but, as business owners, they were also often 
their employer. Female GPs were also seen to be providing resistance to this 
evolution as cervical screening had historically been seen as their domain which 
created power struggles and obstructed collaborative practice (Mills & Fitzgerald, 
2008).  In Australia the MBS benefit for immunisation provided by a nurse is 
considerably less than when performed by a GP and it has been suggested that in 
some practices, although the PN is performing the task, the GP claims for the 
service on behalf of the PN in order to receive a greater benefit (Hoare et al., 2012). 
Practice of this kind clearly undermines the professional role of the PN and could 
lead to inaccurate government reporting of the usage of nurse-led care in the primary 
care setting (Mills & Hallinan, 2009). 
A survey of  284 practice nurses in Australia in 2008 found that the most cited barrier 
to role extension of the practice nurse for cardiovascular disease management was 
legal implications (n=144, 51%). These respondents identified GPs as being hesitant 
to allow practice nurses to perform tasks without direct supervision due to fear of 
litigation (Halcomb, Davidson, Griffiths, et al., 2008). Although not specified in the 
article, it is clear from the data presented that respondents were able to select more 
than one barrier.  Other barriers cited included lack of space/equipment (n=86, 
30.8%), a belief by respondents that their current role is appropriate (n=83, 29.7%) 
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and GP attitudes (n=80, 28.7%). Only four (1.4%) respondents identified inadequate 
remuneration to encourage role extension and fifteen (5.3%) identified deficient 
funding models that impede the provision of additional services (Halcomb, Davidson, 
Griffiths, et al., 2008). Most of the respondents were female (99%), registered 
Nurses (86%) with a mean age of 45.8 years. More than half (63%) indicated that 
their highest level of qualification was a hospital nursing certificate (Halcomb, 
Davidson, Griffiths, et al., 2008).    
Such findings suggest that despite the evidence of successful implementation of 
models of nurse-led care in the primary care setting (Eley et al., 2013), Australia is 
still progressing and may require intervention by means of legislative, educational 
and funding revision in order to allow nurse-led or collaborative care to fulfill it’s 
potential. 
 
2.3     Nurse-led interventions in Hypertension 
While hypertension is a key risk factor for not only PAD but cardiovascular disease 
also, it is estimated that in more than one third of people with hypertension, it is 
uncontrolled (McAlister et al., 2011). Reduction of elevated blood pressure (BP) has 
been associated with a decreased incidence of stroke (35-40%), MI (20-25%) and 
heart failure (>50%) (Chobanian et al., 2003). Reduction of blood pressure requires 
an organised approach which may include lifestyle modifications and appropriate 
dosing and/or combining of antihypertensive medication (Chobanian et al., 2003; 
Clark, Smith, Taylor, & Campbell, 2010). Hypertension is most often managed in the 
primary care setting, however doubt persists as to which members of the primary 
care team provides the most most effective management (Clark et al., 2010). 
Barriers to effective hypertension management may be patient or clinician related. 
Patients issues may include cultural beliefs, financial burden which can impact upon 
medication commpliance, GP contact, and dietary intake, and lack of education 
regarding hypertension management and the associated risks and potential benefits 
from antihypertnsive therapy (Chobanian et al., 2003). For clinicians, a lack of 
knowledge of the current management guidelines  may lead to under-prescribing of 
antihypertensive therapy and a shortage of time during patient consults can result in 
less than thorough patient education. 
In one of the earlier trials comparing nurse and doctor management of hypertension, 
457 participants were enrolled to compare hypertension management provided by 
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specially trained nurses at the participants workplace and that of GPs (Logan, Milne, 
Achber, Campbell, & Haynes, 1979). Nurses were permitted to prescribe and adjust 
medication without doctor approval after having completed an education program in 
which they were taught to manage hypertension according to a set protocol. The 
results indicated that people with hypertension who were managed by a nurse were 
more likely to be prescribed antihypertensive medication (94.7% v 62.7%), to 
achieve target blood pressure in six months (48.5% v 27.5%) and be compliant in 
taking their prescribed medication (67.6% v 49.1%) (Logan et al., 1979).  
In a 2010 systematic review and meta-analysis (Clark et al., 2010) which included 33 
studies spanning 30 years (1979-2009) , it was found that in comparison to usual 
care, nurse-led interventions that included a stepped treatment algorithm 
demonstrated a significantly greater reduction of both systolic and diastolic blood 
pressure.  However this did not translate into a greater achievement of blood 
pressure targets. Studies which included nurse-led prescribing were found to 
demonstrate an even greater reduction of systolic and diastolic blood pressure, while 
telephone monitoring was found to be associated with greater achievement of blood 
pressure targets. 
 
 
2.4      Nurse-led intervention programs for chronic heart failure    
 
Chronic heart failure (CHF) is a deadly and disabling syndrome which affects an 
estimated 10% of people aged 65 years and over, and greater than 50% of people 
aged 85 and over (Krum & Abraham, 2009). The incidence of CHF continues to rise 
due to an ageing population, increased survival rates from coronary artery disease 
and increased incidence of diabetes and obesity (Najafi, 2007). Hospital admissions 
remain common occurrences for people with CHF and mortality rates remain high 
despite improved pharmacological interventions (Dickstein et al., 2008). In a similar 
evolution to the management of CAD, awareness of the increasing burden CHF 
places on the health system has led to the creation of heart failure management 
programs (Boyde, Turner, Thompson, & Stewart, 2011).  
In 1995 Rich et al conducted an innovative prospective randomised control trial 
which demonstrated a 56% reduction in hospital readmissions for CHF patients who 
took part in a nurse-led heart failure management program (Rich et al., 1995). This 
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nurse-led intervention program lead to improved quality of life, reduced  hospital 
readmissions and health care cost (Rich et al., 1995). Subsequent systematic 
reviews have demonstrated similar efficacy of nurse-led intervention programs for 
CHF (Gonseth, Guallar-Castillon, Banegas, & Rodriguez-Artalejo, 2004; Holland et 
al., 2005; McAlister, Stewart, Ferrua, & McMurray, 2004; Phillips, Singa, Rubin, & 
Jaarsma, 2005).  
In 2011, the National Benchmarking and Evidence-Based National Clinical 
Guidelines for Heart Failure Management Programs (BENCH) study examined the 
results of nurse-led titration of beta-blockers in 48 Australian Heart Failure 
Management Programs (Driscoll, Krum, Wolfe, & Tonkin, 2011). The study found 
that patients participating in a nurse-led titration program were more commonly 
prescribed the target dose of beta-blocker and suffered fewer hospitalisations or 
death than those in programs with no nurse-led titration of medications. 
Participants in nurse-led CHF programs have identified that they were satisfied with 
the content provided by their program and that even the more intensive program was 
not a burden. This is significant as it has also been proven that people with severe 
heart failure may require a high level of support including home visits in order to 
achieve educational goals (Hoekstra, Lesman-Leegte, van der Wal, Luttik, & 
Jaarsma, 2010).    
Nurse-led multidisciplinary CHF management programs have now become the gold 
standard treatment in guidelines for the management of people with CHF (Davidson, 
2010; Krum et al., 2006) and are becoming increasingly incorporated into the clinical 
setting to reduce re-admissions and improve the quality of life and survival of people 
with CHF (Lambrinou, Kalogirou, Lamnisos, & Sourtzi, 2012). 
 
2.5      Nurse-led intervention programs for atrial fibrillation 
 
Atrial fibrillation (AF) is the most common cardiac arrhythmia (Heeringa et al., 2006) 
and, it’s incidence markedly increases with age from around 1% in people aged 50 
years to almost 10% in people aged 80 years or more (Wolf, Mitchell, Baker, Kannel, 
& D'Agostino, 1998). The management of AF poses significant strain on health care 
resources in a similar manner to CHF (Carrington et al., 2013). Without effective 
management to reduce the risk of thromboembolic events and tachycardia-induced 
cardiomyopathy, chronic AF can lead to heart failure or stroke (Stewart, Hart, Hole, & 
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McMurray, 2001). Following the successful implementation of nurse-led CHF 
programs, trials of nurse-led multidisciplinary AF programs began to emerge. In 
2004, a nurse-led multidisciplinary home-based intervention for people with chronic 
AF found that  overall home-based intervention was associated with a 25% reduction 
in recurrent hospital stay compared to “usual care” post discharge (Inglis et al., 
2004). It also identified a strong statistical trend towards improved survival for those 
receiving home-based intervention during the 5 year follow-up. A more recent 
randomised control trial (RCT) of nurse-led versus usual care for patients with atrial 
fibrillation found nurse-led care to be superior to usual care provided by a 
cardiologist in terms of hospitalisation rates and cardiovascular mortality (J.  
Hendriks et al., 2012). In a subsequent economic analysis of the same trial, it was 
determined that nurse-led care is a cost-effective management strategy when 
analysed in terms of quality-adjusted life-year (J. Hendriks, Tomini, van Asselt, 
Crijns, & Vrijhoef, 2013).  
      
2.6      Nurse-led intervention programs for Diabetes 
Every day in Australia approximately 280 people are diagnosed with diabetes 
(NDSS, 2012). It is the fastest growing chronic disease in the country with almost 
one million individuals diagnosed and an estimated one million more who are yet to 
be diagnosed.  According to Diabetes Australia;  
‘there is an urgent need for increased understanding of the economic, 
and societal seriousness of diabetes and its complications, and of the escalating 
costs to individuals, families, workplaces, society and governments. We need 
sustained, nationally consistent programs to prevent, detect and manage diabetes in 
Australia. Too many plans have been designed and not properly implemented or 
evaluated….We need to ensure funding for quality treatment is available and 
accessible to all to prevent or delay the onset of diabetes and its complications.’ 
(Diabetes Australia) 
 
People with diabetes benefit from frequent regular contact with health professionals 
regardless of the level of intervention (Woodward, Wallymahmed, Wilding, & Gill, 
2005). However nurse-led case management of diabetes has demonstrated a 
clinically significant improvement in mean blood glucose management as measured 
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by HbA1c when compared with physician-led outpatient services (Welch, Garb, 
Zagarins, Lendel, & Gabbay, 2010).  
Structured nurse-led counselling based on motivational interviewing has not been 
shown to alter HbA1c or lifestyle related to diet and physical activity (Jansink et al., 
2013). Therefore while nurse-led care for diabetes has indeed demonstrated efficacy 
(McLoughney, Khan, & Ahmed, 2007; Welch et al., 2010), there are limitations to the 
extent of this improvement, which could possibly be improved with the 
implementation of a multidisciplinary approach.  
 
2.7      Nurse-led intervention programs for PAD  
The American College of Cardiology/American Heart Association (ACC/AHA) and  
Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral 
Arterial Disease (TASC II) guidelines for the management of PAD include both 
supervised exercise and aggressive risk factor modification in order to reduce 
cardiovascular risk (Hirsch et al., 2006; Norgren et al., 2007). PAD intervention 
programs (both nurse-led and non-nurse-led) have demonstrated improvements in 
functional capacity, quality of life and some cardiovascular risk factors (table 1). 
However examination of this evidence identifies areas within the field requiring 
further investigation.   
      Nurse-led Studies 
While there have been multiple studies examining the optimal modality, length and 
level of supervision required for a PAD exercise program (Gardner, Montgomery, & 
Parker, 2012; Hiatt, Wolfel, Meier, & Regensteiner, 1994), there is a paucity of 
evidence regarding nurse-led intervention programs which incorporate both 
supervised exercise and risk factor modification which have been assessed through 
multiple outcome measures over a sustained time period.  
 With evidence demonstrating improved walking distance in people with claudication 
through exercise (Skinner & Strandness, 1967), and following the successful 
introduction of structured rehabilitation programs for Coronary Artery Disease,  
vascular rehabilitation programs for people with PAD began to emerge in the United 
States (US) in the early 1980’s (Williams, Ekers, Collins, & Lee, 1991). Whilst they 
have become common in the US and Europe, only a handful of vascular units in 
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Australia have embraced these programs. Additionally very few are currently nurse-
led (personal communication).  
The main aim of an intervention program for people with PAD is to reduce the 
associated cardiovascular risk and so having vascular nurses involved in the 
supervision of these programs is important (Hirsch et al., 2006; Spronk, Dolman, 
Boelhouwer, Veen, & den, 2003).   
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Table 3 
 
First 
Author 
Year Study type Participants (n) Intervention Follow-
up,  
Months 
Functional 
Assessment 
Method  
Additional 
Outcome 
 Measures 
Results 
Nurse-led Programs 
Braun  1999 Retrospective 
analysis 
22 12 week supervised Exercise  + 
risk factor modification education 
24 
 
 
Treadmill Test  Increased ° 
 
 
Spronk 
 
2003 Prospective 
study 
104 
 
 
8-16 week Home-based exercise 
program + risk factor modification 
4 Corridor walking 
assessment 
 Increased ° 
Sillesen 2007 Prospective 
cohort study 
693 
 
12 Months=331 
Exercise advice + risk factor 
modification 
12 
 
 
 
Questionnaire  
 
Risk Factors  
(mean TC, LDL, BP) 
Increased** 
 
Improved** 
 
 
Hatfield  2008 Prospective 
study 
78 Exercise advice + Structured risk 
factor modification 
3  Framingham 
Risk 
Improved**  
Simmons 2013 Quality 
improvement 
project 
17 Home-based exercise  1 Questionnaire  Increased 
frequency of  
exercise^ 
Non-Nurse-led Programs 
Franz 2010 Prospective 
study 
47 12 week supervised exercise 
program + risk factor modification 
3 Treadmill Test & 
12 Minute Walk 
 
 
 
 
Risk Factors 
(Mean BMI, BP, 
Lipids)  
Increased** 
 
 
 
Improved^  
 
 
Fakhry  2011 Comparative 
longitudinal 
cohort study 
Group 1      142 
 
 
Group 2        75 
 
24 Week structured home 
exercise program 
 
24 Week supervised exercise 
program 
12 
 
 
Treadmill 
 
 
Treadmill 
 
QOL 
 
 
QOL 
Increased**  
Increased**  
 
Increased**   
Increased**  
Guidon 2013 Randomised 
control trial 
Group 1       17 
 
 
Group 2       12 
12 week supervised exercise 
program  
 
Exercise advice 
12 Questionnaire 
 
 
Questionnaire 
 
QOL 
  
 
QOL 
Increased^ 
Increased^  
 
Decreased 
Decreased 
 
^= not statistically significant       **=p<0.001        °=p value not stated      QOL=Quality of Life assessment 
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It is imperative that patients are provided with education regarding risk factor 
modification. It must also be clearly explained to the patient that the objective is not 
only to improve walking distance but, more importantly, to reduce the risk of 
atherosclerotic disease progression. Vascular nurse supervision provides the 
opportunity for patients to develop a rapport with a health professional and to 
continue to feel supported and motivated to establish routines which involve positive 
lifestyle changes which may otherwise be difficult to achieve (Spronk et al., 2003).    
While the current evidence regarding nurse-led intervention programs for PAD is 
minimal, improvement in functional capacity and cardiovascular risk through 
optimising certain cardiovascular risk factors has been clearly demonstrated (table 
3). 
 
   Non-Nurse-led Studies 
Although non-nurse-led intervention programs may lack the intensive risk factor 
modification of a nurse-led program, they have demonstrated efficacy in improving 
functional capacity and quality of life (Fakhry, Spronk, de, den, & Hunink, 2011; 
Franz, Garwick, & Haldeman, 2010; Guidon & McGee, 2013). (Table 3) 
Fakhry et al’s comparative longitudinal cohort study (2011) compared the results of a 
non-nurse-led structured home exercise program and a non-nurse-led supervised 
exercise program. The participants in the latter group were also enrolled in a 
concurrent RCT comparing supervised exercise to peripheral stenting. Due to the 
extensive inclusion criteria for the RCT, the structured home-program enrolled twice 
as many participants. Both groups demonstrated statistically significant improvement 
in functional capacity and quality of life at 12 months. However, the supervised 
exercise group demonstrated a far greater improvement in functional capacity than 
those in the structure home program group (Fakhry et al., 2011).  
   
 Limitations of existing studies 
The number of participants in studies regarding PAD intervention programs are 
generally lower than those of other disciplines; with only 20-59 participants, on 
average, due to advancing age and extensive co morbidities (C. J. Watson et al., 
2008). While the study by Sillesen et al (2007) recruited 693 participants over four 
years, they also reported an attrition rate of greater than 50% by 12 months. 
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Similarly, the second largest nurse-led study (Spronk et al., 2003) which recruited 
104 participants suffered a 30% attrition rate in just 16 weeks.  
 In addition, the Sillesen study, as with much of the PAD literature, assessed 
functional capacity through questionnaire alone. A potential weakness of this 
approach is that it is simply measuring changes in patient-perceived functional 
capacity.  Assessing functional capacity by questionnaire alone can lead to 
inaccuracies as it has been shown that participants frequently make errors when 
completing the self-reporting tools (Mahe et al., 2011).  and when estimating walking 
distances  (L. Watson & Collin, 1998). It can also be the case that, following an 
intervention program, participants may feel an obligation to report an improvement or 
may even perceive that there has been an improvement when, in fact, their 
functional capacity has not improved (Enright, 2003).  
Functional testing by means of treadmill testing may also represent a relatively 
artificial means of quantifying walking capacity as it is performed according to a 
protocol which automatically specifies walking speed and gradient. For this reason, it 
is recommended that studies evaluating functional capacity should include both a 
treadmill and a corridor-based functional assessment , such as the six-minute walk, 
which few of the existing studies do (McDermott et al., 2008).  
A further, and critical, limitation of the existing research is the lack of randomised 
control trials. This is a challenge for researchers due to the specific 
recommendations of the ACC/AHA guidelines which recommend a supervised 
exercise program as initial treatment for all people with PAD (Hirsch et al., 2006).  
Many of the published studies also suffer from a lack of long-term follow-up.  It is 
important to determine whether or not the functional improvements the participants 
have experienced during the study are still evident after a long follow-up term.  
 
In all nurse-led interventions, the nurse can play a vital role in coordinating care, 
providing education and establishing a trust that can have a meaningful impact upon 
people’s health and quality of life (Lovell, Myers, Forbes, Dresser, & Weiss, 2011). 
For nurse-led interventions in the field of PAD, further research is required in order to 
address some of the shortfalls identified in the existing evidence.  
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Chapter 3 
Methodology 
The following chapter will describe the research methodology used for this study, 
including the recruitment and inclusion/exclusion of participants. It will describe in 
detail the nurse-led intervention program and the parameters used for analysis.   
In order to address the research question: 
Can a nurse-led intervention program for people with peripheral arterial lead 
to sustained improvement in functional capacity and quality of life? 
section 3.5 will address how functional capacity was measured followed by 3.6 which 
will describe the tools which were used to measure quality of life in the participants. 
 
3.1   Sample & Setting 
Participants were recruited from both the Vascular Outpatients department and 
Vascular Ward at the Princess Alexandra Hospital in Brisbane, Australia between 
March 2009 and December 2011. Eligible participants were identified through chart 
review and contacted by a research nurse to discuss involvement in the study. All 
potential participants were informed that participation was voluntary and declining to 
participate would not alter their ongoing medical management.  
Ethical clearance was obtained for the study from both Metro South Human 
Research Ethics Committee (HREC/08/QPAH/221) and University of Queensland 
Human Research Ethics committee (2009000187). All participants gave written 
informed consent.  
 3.2   Inclusion Criteria 
Participants had to be aged between 18 and 80 years of age and have a diagnosis of 
peripheral arterial disease confirmed by either: 
 Positive Edinburgh claudication questionnaire (Leng & Fowkes, 1992) 
 Ankle-brachial index ≤0.8  (Hirsch et al., 2006) 
 Previous diagnostic examination including duplex or angiogram 
3.3  Exclusion Criteria 
Participants were excluded if they were: 
 Clinically unfit to take part in the vascular intervention program due to 
conditions such as class III-IV angina, severe heart failure or end stage renal 
failure 
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 Scheduled for major vascular surgery 
 Found to have critical limb ischemia 
 Pregnant 
 Unable to present for follow-up testing 
 Unable to provide written informed consent 
 
 
3.4  Data Collection  
 Past Medical History 
Participants were interviewed by the research nurse for a full medical/surgical history 
including current medications and cardiovascular risk factors, including: 
 History of cardiovascular disease 
 Smoking status and number of pack years 
 Hypertension 
 Family history of cardiovascular disease 
 History of diabetes mellitus/metabolic syndrome 
 Previous surgeries/interventions 
 Current exercise and activity levels 
 
 Clinical Examination 
All participants underwent a full vascular assessment which included: 
 Systolic and Diastolic blood pressure 
 Heart rate 
 Height  
 Weight 
 Body Mass index 
 Waist and Hip Measurement 
 Assessment of pulses (femoral, popliteal, posterior-tibal, & dorsalis-pedis) by 
manual palpation or hand-held Doppler when impalpable.   
 ECG 
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Pathology 
The following blood tests were obtained: 
 fasting lipids (total cholesterol, HDL, LDL & Triglycerides)  
  HBA1C for diabetic participants. 
 
 
 Ankle-Brachial Index 
Ankle-brachial index (ABI) is a simple non-invasive method of assessment which can 
be helpful in the diagnosis and severity scoring of both symptomatic and 
asymptomatic PAD (Norgren et al., 2007). A reduced ABI has been shown to be  a 
strong predictor of future cardiovascular events, with the level of risk correlating to 
the degree of reduction in ABI, independent of other risk factors (Figure 3.1)(Resnick 
et al., 2004).  PAD can be diagnosed if ABI≤0.90 (Olin et al., 2011). A ratio of greater 
than 1.30 suggests poorly compressible, calcified arteries (Arain & Cooper, 2008) 
which can be a common occurrence in the diabetic population.  
 
Figure 3.1 
 
Reproduce with permission (Resnick et al., 2004) 
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For this study ABI was measured using a handheld continuous wave Doppler 
ultrasound device (5mhz) and a manual sphygmomanometer. The higher systolic 
pressure measured from either the posterior tibial or dorsalis pedis artery (in each 
leg) was divided by the higher brachial artery pressure taken from either arm (figure 
3.2) as per the TASC II guidelines (Norgren et al., 2007). 
 
 
Figure 3.2 Reproduced with permission (Hiatt, 2001) 
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3.5 Functional Assessment 
Six Minute Walk 
The six-minute walk test is a method of assessing walking capacity which has 
demonstrated excellent test re-test reliability in people with PAD (Montgomery & 
Gardner, 1998). Corridor-based functional performance measures such as the six-
minute-walk are an important complement to treadmill assessment as they have 
been shown to correlate better with physical activity during daily life, and it is 
recommended that studies of functional performance in persons with PAD should 
include both (McDermott et al., 2008). 
Participants performed the six minute walk test according to a set protocol which 
instructed participants to walk up and down a measured and marked 25 metre lap of 
a corridor as many times as they could in a six minute time frame. All participants 
received identical instructions. The distance they were able to walk was recorded in 
metres as well as the number of times they had to stop within the six-minute time-
frame.  
 
 
The Progressive Treadmill Test 
Treadmill testing is also an established means to quantify walking ability in persons 
with PAD and is highly predictive of long-term morbidity and mortality out-comes (de 
Liefde et al., 2009). Treadmill walking is frequently used to measure changes in 
walking ability following interventions in people with PAD (McDermott et al., 2008). It 
has potential advantages including ease of direct comparison of results due to a 
tightly controlled setting and use of a stardardised protocol. However it has also 
been criticised as creating a more “artificial” environment when compared to corridor-
based testing and baseline tests may in fact be limited by anxiety and the persons 
inexperience with walking on a treadmill rather than actual functional limitation 
(McDermott et al., 2008).   
In cardiology the Bruce protocol is used as a standardised protocol for exercise 
stress testing (table 1) (Bruce, Kusumi, & Hosmer, 1973). It increases speed and 
incline every 3 minutes in order to elevate heart rate to near age-correlated-
maximum to identify possible signs of cardiac ischemia.  
In PAD assessment, there are a wide variety of treadmill protocols which are used, 
and have been validated, however no protocol in particular has been universally 
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accepted. The two main types of treadmill protocols used are continuous, where 
speed and incline are not adjust throughout the test, or graded where speed and 
incline are commenced at a lower workload and then both are increased at set times 
throughout the test. Continuous protocols have proved difficult to use in the PAD 
population due to the wide variety in walking abilities and comorbidities amongst 
sufferers. The high initial workload of a continuous test is also not well tolerated by 
persons with severe PAD. Graded treadmill protocols have also demonstrated a 
greater reliability than continuous protocols when using maximum walking time as 
the primary outcome measure (Nicolai et al., 2009).     
The progressive treadmill test (PTT) is a graded treadmill test which was devised 
specifically for people with PAD and was the treadmill test used in this study (table 
3.1) (Braun, Colucci, & Patterson, 1999). Although both the PTT and Bruce are 
graded treadmill tests, the PTT has a more gradual increase in speed an incline 
which is better tolerated in the PAD population than the Bruce protocol. 
To perform the Progressive Treadmill Test, participants were commenced at stage 
1.6 km/hr with a 5% incline and continued along the protocol increasing speed and 
incline at the set times until they felt they could not walk any further. The participants 
were asked to alert staff when they began to experience claudication pain during the 
test and this time was noted as claudication pain time (CPT). When they could no 
longer continue, the time was documented as maximum walk time (MWT). Both 
measures were documented in minutes and seconds. 
CPT and MWT have been used in multiple studies demonstrating improvements in 
both pain-free and total walking time post intervention for PAD (Gardner et al., 2001; 
Gardner, Parker, Montgomery, Scott, & Blevins, 2011; Haluska, 2013). 
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Table  3.1 
 
MINUTES 
 
 
Progressive Treadmill Test Bruce Protocol 
Speed 
km/hr 
Incline 
% 
Speed 
km/hr 
Incline 
% 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
1.6  
 
 
 
2.4 
 
 
 
 
3.2 
 
 
 
 
4 
 
 
 
 
4 
5 
 
 
 
10 
 
 
 
 
10 
 
 
 
 
10 
 
 
 
 
15 
 
 
2.7 
 
4 
 
 
5.5 
 
 
6.8 
 
 
8 
 
 
8.8 
 
 
9.6 
 
 
10.5 
 
 
11.3 
10 
 
12 
 
 
14 
 
 
16 
 
 
18 
 
 
20 
 
 
22 
 
 
24 
 
 
26 
(Braun et al., 1999; Bruce et al., 1973) 
3.6  Quality of Life assessment 
All participants were asked to complete both an SF12   and Vascuqol  quality of life 
questionnaire both prior to commencing the Nurse led intervention program and 
again at intervals of 12 months, 24 months and 30 months.  
While treadmill and corridor walk testing are able to provide information regarding a 
PAD sufferers walking ability, they do not address their perception of his or her 
walking ability or health related quality of life (HRQOL). In addition, other elements of 
health status, such as mental health, emotional well-being, and social functioning, 
can only be assessed by questionnaires (Mays et al., 2011). 
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General Quality of Life Assessment Tools  
The Short Form 36 (SF-36) Questionnaire is a general HRQOL tool which provides a 
brief yet comprehensive assessment of HRQOL (J. E. Ware, Jr. & Sherbourne, 
1992). It measures eight domains: physical, role and social functioning, mental 
health, patient health perceptions, vitality, bodily pain, and change in health (Mays et 
al., 2011) and has been extensively validated for assessing HRQOL in symptomatic 
PAD patients (Turner-Bowker, 2002). The Short Form 12 (SF-12) questionnaire (J. 
E. Ware, Jr. & Sherbourne, 1992) extracts select items from all eight domains of the 
SF-36 and includes the same physical and mental component (Mays et al., 2011). It 
was designed to be a simpler version of the SF-36 and because it is a relatively short 
questionnaire compared with other general health questionnaires, it can be a more 
practical option for use in clinical settings (Mays et al., 2011). It is due to this 
practicality that the SF12 was chosen as the general quality of life tool for this study 
(Appendix 1). The SF12 consists of 12 questions which are scored from 1 to 3 or 1 to 
5, with the lowest scores representing the higher QOL response. The advantage of 
generic questionnaires is that they can be used for evaluating QOL for various types 
of diseases and for calculating utility values in cost-effectiveness analysis. However, 
they are considered to be less sensitive to detect small but clinically significant 
differences in treatment effects because they do not focus on specific effects of 
disease (Mehta, Venkata, Chetter, & McCollum, 2003).   
 
 
PAD Specific Quality of Life Assessment Tool 
The Vascular Quality of Life (VascuQol) (Morgan, Crayford, Murrin, & Fraser, 2001) 
questionnaire is a disease-specific tool which measures more specific elements of 
PAD and thus it is more sensitive to measuring more subtle effects after treatment. 
The VascuQol contains 25 questions subdivided into 5 dimensions: pain, symptoms, 
activities, social, and emotional. Each question has a 7-point response option with 
the lowest mark (1) being assigned to the answer representing the poorest QOL and 
the highest mark (7) assigned to the answer representing high QOL (Appendix 2)  
(Morgan et al., 2001). 
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The domains in each tool were analysed to identify if an improvement was evident 
not only following the nurse led intervention program, but if any improvement was in 
fact sustained over a 30 month time period.  
Participants who underwent revascularisation or major amputations during the study 
period were eliminated from analysis as it would not be possible to identify which 
intervention led to any improvements or decline in their quality of life.  
Quality of life only Group 
A sub-group of people who were unable (due to geographical location) to attend the 
Vascular Intervention Program were sent exercise and risk factor modification 
information. They then completed quality of life questionnaires and gave consent for 
access to their medical record and telephone follow up for 30 months. Due to a lack 
of randomisation, this group cannot act as a true “control” group for the study.  
  
3.7    Nurse-led Intervention Program 
After completing baseline testing all participants began the Nurse-led intervention 
program which included: 
 Attending a 12 week nurse-led exercise and risk factor modification program 
 Contacting participants GP to inform them of participants inclusion in study as 
well as communicate suggestions for medical therapy optimisation.  
 Referring participants for additional education/intervention where indicated 
(smoking cessation and diabetic education) 
 Setting a home walking program for participants to continue with once they 
had completed the supervised exercise program 
 
Supervised Exercise Program 
This 12 week program took place at the Princess Alexandra Hospital one day per 
week and consisted of: 
 1 hour exercise sessions, comprised of warm up stretches, followed by six 5- 
minute circuit stations and cool down stretches. The circuit training was 
tailored for individual ability and included: 
 Exercise bike 
 Rowing machine 
 Arm ergometry  
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 Free weights 
 Step ups 
All participants also completed 2 treadmill stations per session as published 
evidence suggests that walking is the preferable mode of training for 
improvement in functional capacity in people with PAD (Gardner & Poehlman, 
1995; Hiatt et al., 1994). Circuit stations alternated upper and lower body 
exercises to allow claudication pain to subside while keeping heart rate up to 
improve cardiovascular fitness. 
Exercise sessions were supervised by both an experienced Vascular Nurse and 
Physiotherapist. Vital signs including blood pressure, pulse, and blood glucose level 
for diabetics were assessed both before and after exercise.  
 
Risk Factor Modification Education 
The ACC/AHA guidelines for the management of PAD recommends aggressive risk 
factor modification in order to reduce the extreme associated cardiovascular risk 
(Hirsch et al., 2006).  Consequently, education and assistance with risk factor 
modification was an essential element of the nurse-led intervention program. 
On 5 of the 12 week visits for the nurse-led intervention program, participants 
attended education lectures regarding risk factor modification. They included: 
Table 3.2 
Title Presenter/Educator Educational Focus 
“Peripheral Arterial 
Disease” 
Vascular Nurse  What is PAD? 
 Causes, Symptoms 
and treatment options 
“Hypertension & Salt Skip” Hypertension Clinical 
Nurse Consultant 
 What is ‘optimal’ blood 
pressure? 
 Benefits of home BP 
monitoring 
 Salt reduced diet 
“Dietary Management of 
PAD” 
Dietician  Good fats/Bad Fats 
 What makes a 
balanced diet? 
 Portion control 
“PAD Medications” Pharmacist  Anti-platelet drugs 
 Warfarin 
 Statins 
 Possible side effects 
and necessary 
precautions 
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“Exercise & PAD” Physiotherapist  How can exercise help 
PAD? 
 Safety precautions 
when exercising 
 Goal setting 
 Home exercise 
 
Diabetic participants were referred to the diabetic education program run by the 
hospital endocrine department to increase their understanding of dietary choices for 
improved diabetic management as well as other important associated complications 
including neuropathy, and foot care.   
Participants who continued to smoke were referred to the hospital alcohol and drug 
dependency unit for support with smoking cessation. 
 
 
 
3.8 Statistical Analysis 
Continuous variables are expressed as mean +/- SD or as median (interquartile 
range); categorical variables are expressed as percentages.  
Student’s t tests were used to compare differences between two groups for 
continuous variables. Chi-square tests were used to determine significant differences 
between two groups of categorical variables. Analysis of variance with Bonferroni 
post hoc analysis was used to determine differences across and between groups 
when >2 groups were present. A p value <0.05 was considered significant. Pearson 
correlation coefficient was calculated to measures the strength of the linear 
relationship between normally distributed variables. The Spearman rank correlation 
method was used when variables where not normally distributed. 
Linear regression analysis was used to identify univariate predictors. Variables with 
statistical significance on univariate analysis of >0.1 were selected for inclusion in 
the model.  
 All statistical analysis was performed using the Statistical Packages for Social 
Sciences software (SPSS Inc, Chicago, Il).  
 
 
52 
 
Chapter 4 
Research Findings 
4.1   Introduction 
This chapter will discuss the findings from the research conducted. Section 4.2 will 
discuss the participant demographics and clinical outcomes, while 4.3 and 4.4 will 
present the results pertaining to functional capacity and quality of life respectively.  
4.2  Participant Demographics 
137 potential participants with symptomatic Peripheral Arterial Disease were 
identified for the study. Of this group, 56 people consented to taking part in the 
nurse-led intervention program and a further 23 individuals who were unable to 
attend the intervention program agreed to complete quality of life-only follow-up.  
The baseline demographics for both the nurse-led intervention program (NLIP) group 
and the quality of life-only (QOLO) group are detailed below (Table 4.2.1). As the 
QOLO group were unable to attend for physical testing, some data was unable to be 
collected. The only statistically significant difference between the groups was the 
male/female ratio, with the NLIP group comprising around 80% male and the QOLO 
group only 47.8% male. The prevalence of PAD in men and women has been 
reported differently in many studies, however most studies identify a higher 
prevalence of symptomatic PAD in the male population with ratio’s varying between 
2:1 and 3:1 (Norgren et al., 2007). 
Although the participants in the NLIP group had a high rate of hypertension and 
hyperlipidaemia, baseline mean blood pressures and lipid markers were within the 
ACC/AHA target limits demonstrating reasonable management of these risk factors 
(Hirsch et al., 2006). HbA1C was only marginally above the target limit of 7%, which 
again suggests the diabetic participants were managing their diabetes moderately 
well. 
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Table 4.2.1 
 NLIP 
N=56 
QOLO 
N=23 
p 
Male 45 (80.4%) 11(47.8%) .003 
Age 66.5±10.1 66.8±7.8 ns 
BMI 29±5.2 n/a n/a 
Systolic BP 132±18.6 n/a n/a 
Diastolic BP 69.6±10.4 n/a n/a 
ABI (mean) 0.68±0.16 n/a n/a 
Total Chol (mmol/L) 4.2±1.2 n/a n/a 
LDL (mmol/L) 2.2±0.8 n/a n/a 
HDL (mmol/L) 1.05±0.38 n/a n/a 
HbA1C (%) 7.06±1.2 n/a n/a 
History    
Hypertension 49 (87.5%) 18 (78.3%) ns 
Coronary Artery Disease 27 (48.2%) 9 (39.1%) ns 
Diabetes Mellitus 30 (53.6%) 8 (34.8%) ns 
Hyperlipidaemia 47 (84 %) 20 (87%) ns 
CVA 10 (17.9%) 5 (21.7%) ns 
Current Smoker (within 12 
months) 
27 (48.2%) 7 (30.4%) ns 
Previous peripheral Bypass 8 (14.3%) 4 (17.4%) ns 
Previous peripheral stent/plasty 7 (12.5%) 3 (13%) ns 
Medications    
Statin 56 (100%) 19 (82.6%) ns 
Antiplatelet therapy 45 (80.3%) 18 (78.3%) ns 
Warfarin 9 (16%) 2 (8.7%) ns 
ACE inhibitor 26 (46.4%) 6 (26.1%) ns 
Beta Blocker 24 (42.9%) 9 (39.1%) ns 
n/a= not available    ns=not statistically significant 
 
 
Clinical Outcomes 
Participants in both groups were followed up for a mean time of 52 ± 9 months for  
number of cardiac admissions, peripheral angioplasty or stent, peripheral arterial 
bypass, major lower limb amputations and all-cause mortality (Table 4.2.2).  Six 
participants in the NLIP group and 4 in the QOLO group were lost to follow up. The 
QOLO group did undergo a statistically significantly higher rate of peripheral arterial 
bypass than that of the NLIP group over the follow-up time. 
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Table 4.2.2 
 NLIP 
N=50 
QOLO 
N=19 
p 
Cardiac Admission 11 (22%) 7 (36%) ns 
Peripheral Stent/Angioplasty 9 (18%) 3 (16%) ns 
Peripheral Arterial Bypass 2 (4%) 2 (11%) <.001 
Major Lower Limb amputation 2 (4%) 1 (5%) ns 
Death 7 (14%) 2 (11%) ns 
 
4.3 Functional Capacity Assessment Results 
3 Months 
The functional capacity assessment results following the 12 week Nurse-led 
Intervention program were indeed consistent with improvements noted in other PAD 
studies (C. J. Watson et al., 2008) with both Claudication Pain Time (CPT), and 
Maximum Walk Time (MWT) demonstrating a statistically significant improvement 
(Table 4.3.1). Also consistent with other studies in the PAD population, was a 
moderate attrition rate with only 37 of the original 56 participants completing the 12-
week Intervention Program (Sillesen, Madelung, Eldrup, & Roed, 2007; Spronk et al., 
2003). All of the 19 people who did not complete the program cited medical reasons 
for non-completion. 
Table 4.3.1 
 n Baseline 3 Months p 
CPT (seconds) 37 264±199 612±749 .005 
MWT (seconds) 37 541±310 854±437 <.001 
 
12 Months 
12 Months following their baseline testing, all participants were asked to return for 
follow-up physical testing, however only 25 participants were able to return to 
perform a six-minute walk test, and  of them only 19 were able to complete a 
progressive treadmill test. This was due to physical limitations they were 
experiencing such as knee, hip or back concerns which would render them unfit to 
safely attempt the treadmill test. As corridor testing is able to be performed at an 
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individual’s own pace, they were able to perform a six-minute walk test. The 
functional assessment results of the group remained statistically significantly 
improved when compared to their baseline assessment results (Table 4.3.2). 
 Table 4.3.2 
 n Baseline 12 Months p 
CPT (seconds) 19 259±177 517±315 .004 
MWT (seconds) 19 569±319 688±334 .043 
6 Min Walk (metres) 25 308±97 349±97 .03 
 
30 Months 
The final assessment for functional capacity was performed 30 months following the 
commencement of the Nurse-led Intervention Program and while 35 of the 37 people 
who completed the program returned for final testing, only 13 were able to perform a 
progressive treadmill test. The improvement in functional capacity which had been 
evident up until the 12 month time-point, had at this stage begun to show signs of 
decline. (Table 4.3.3) 
Claudication pain time continued to be statistically significantly improved when 
compared to baseline results, and while the means of the maximum walk time and 
six-minute walk time appear to show a continued improvement, the reduction in the 
sample size has meant a loss of statistical significance. This is most likely due to the 
fact that those who were able to perform the treadmill test at 30 months were indeed 
the participants who were more physically fit and could walk a considerable distance, 
even at baseline.  
Table 4.3.3 
 
 
 
 
 n Baseline 30 Months p  
CPT (seconds) 13 257±158 507±333 .045 
MWT (seconds) 13 658±318 716±399 .526 
6 Min Walk (metres) 35 317±107 321±107 .838 
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Figure 4.3.1- Functional Assessment Results 
 
Functional Capacity Correlations 
Both measures of functional capacity (Treadmill and six-minute walk) were found to 
correlate significantly, at baseline and 30 months (Table 4.3.4), suggesting that 
treadmill testing may not be as inaccurate a representation of functional capacity in 
daily life as has been suggested in some literature (McDermott et al., 2008).  
Table 4.3.4 
 r p  
6MW & CPT (Baseline) .59 <.001 
6MW & MWT (Baseline) .65 <.001 
6MW & CPT (30 Months) .53 .06 
6MW & MWT (30 Months) .76 .003 
 
Predictors of functional measures (6MWT, CPT, MWT) were sought, however due to 
the reduced participant numbers at follow-up visits [start = 56, 12 months = 19, 30 
months = 13] only analysis at baseline was feasible.  Univariate predictors are shown 
in table 4.3.5 below. 
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Table 4.3.5 
Functional 
Measure 
Variable β p 
    
6MW    
 BMI -0.321 0.03 
 Total Chol -0.275 0.048 
 Mean ABI 0.279 0.043 
    
CPT    
 BMI -0.342 0.017 
 Total Chol -0.316 0.021 
 Mean ABI 0.275 0.044 
    
MWT    
 Total Chol -0.285 0.04 
 Mean ABI 0.332 0.01 
 
No significant predictors were found in multivariate models to predict 6MW and CPT, 
however in a multivariate linear regression model to predict MWT [overall R2=0.18, 
p<0.01], both total cholesterol [R=-0.289, p=0.032] and mean ABI [R=0.312, 
p=0.021] were found to be significant predictors (figures 4.3.2 and 4.3.3 below]. 
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Figure 4.3.2- Total Cholesterol as a predictor for Baseline MWT  
 
Figure 4.3.3- Mean ABI as a predictor for Baseline MWT 
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Ankle-Brachial Index 
Ankle-brachial index (ABI) did not demonstrate any significant change throughout the 
intervention program. (Table 4.3.6) This was not unexpected as ABI is a measure of 
macrovascular perfusion and although the exact mechanism responsible for 
exercise-related improvements in walking distance in people with PAD has yet to be 
proven conclusively, the evidence to date suggests that it is the result of improved 
endothelial function and muscle-utilisation of available perfusion, both of which would 
not be detected by ABI (Hamburg & Balady, 2011).  
 
Table 4.3.6 
 12 Months 30 Months 
Mean ABI 0.73±0.25 0.67±0.19 
p  (compared to Baseline ABI 0.69±0.16) .332 .263 
 
 
4.4 Quality of Life Assessment Results 
The assessment of quality of life in this study was performed using both a general 
quality of life tool (SF12- Appendix 1) and a PAD specific validated tool (Vascuqol-
Appendix 2).  
Short Form 12 (SF12) Quality of Life Assessment tool (J. E. Ware, Kolinski, M., 
Keller, S.D.,, 1995) is a validated shortened version of the SF36 which assesses 
both mental and physical domains. Participants in the NLIP group were asked to 
complete this survey at baseline (pre-intervention program), 3 months (post-
intervention program) and again at 12 and 30 months. 
Participants in the QOLO group were asked to complete at Baseline, 12 and 30 
months. 
The results of the QOLO group’s SF12 questionnaires showed no significant change 
throughout the study (Table 4.4.1). Those in the NLIP group did not show any 
significant change directly following the 12-week program, however they were 
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significantly improved in both domains at the 12 month time-point. However, this 
improvement was no longer evident by 30 months (Table 4.4.2). 
 
Table 4.4.1- SF12 results  
QOLO Group 
 Baseline 
n=23 
12 Months 
n=9 
30 Months 
n=7 
p 
12 Months 
p 
30 Months 
Mental  45.4±9.7 44.2±7 49.2±6.5 .778 .159 
Physical  35.3±12 39.7±9 38.8±12.5 .117 .824 
 
 
Table 4.4.2- SF12 results 
NLIP Group 
  
Baseline 
n=56 
 
3 Months 
n=31 
 
12 Months 
n=35 
 
30 Months 
n=31 
p 
3 
Months 
p 
12 
Months 
p 
30 
Months 
Mental  49.6±13.4 49.5±11.6 46.5±10.1 46.9±6.3 .978 .010 .963 
Physical  31.1±8.4 32.7±8.5 33.9±11.4 34.4±8.6 .232 .030 .102 
 
While the SF12 is a validated tool to assess quality of life, the Vascuqol is a PAD 
specific quality of life assessment tool which examines 5 domains including Activity, 
PAD symptoms, Pain, Emotion, Social as well as an overall total (Morgan et al., 
2001). The Vascuqol questionnaires were administered to both the QOLO and NLIP 
group at the same time-points as the SF12 questionnaire. 
 Again the QOLO group showed almost no significant change throughout the study 
(Table 4.4.3). The only significant improvement was seen in the domain of pain at 
the 12 month mark. Due to the high attrition rate, it is possible that the QOLO group 
did experience improvement in QOL which was undetectable due to the reduced 
sample size. 
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Table 4.4.3 
Vascuqol- QOLO Group 
 Baseline 
n=23 
12 Months 
n=17 
30 Months 
n=11 
p 
12 Months 
p 
30 Months 
Activity 4.02±1.3 4.28±1.4 4.5±1.3 .261 .881 
Symptoms 5.08±1.2 5.28±1.1 5.73±1 .503 .427 
Pain 4.09±1.5 4.93±1.4 4.93±1.6 .003 .362 
Emotion 5.04±1.5 5.32±1.3 5.87±1.2 .390 .577 
Social 4.72±1.6 4.78±1.6 5.2±1.4 .769 .726 
Total 4.52±1.3 4.88±1.2 5.22±1.2 .154 .578 
 
The NLIP group demonstrated significant improvement in all domains except social, 
at the 3 month time-point, which was directly following the 12 week intervention 
program (Table 4.4.4). The group sustained this significant improvement in the 
domains of PAD symptoms and emotion throughout the 30 months of the study.   
Table 4.4.4 
Vascuqol- NLIP Group 
 Baseline 
n=56 
3 Months 
n=37 
12 Months 
n=42 
30 Months 
n=36 
p 
3 
Months 
p 
12 
Months 
p 
30 
Months 
Activity 3.79±1 4.18±1.3 3.9±1.3 3.86±1.3 .019 .896 .760 
Symptoms 4.34±1.4 5.19±1.2 4.88±1.4 4.89±1.2 .001 .035 .014 
Pain 3.81±1.4 4.46±1.4 4.19±1.4 3.96±1.5 .008 .187 .299 
Emotion 4.35±1.6 4.82±1.6 4.82±1.7 4.67±1.8 .041 .041 .043 
Social 4.30±1.6 4.66±1.6 4.72±1.6 5.22±1.7 .165 .507 .334 
Total 4.08±1.1 4.62±1.3 4.43±1.3 4.33±1.3 .004 .145 .114 
 
Table 4.4.5 
Baseline quality of life comparison 
Vascuqol NLIP group QOLO group p 
Activity 3.51±0.8 3.89±1.3 .296 
Symptoms 3.89±1.3 5.12±0.9 .011 
Pain 3.61±1.4 4.15±1.4 .300 
Emotion 3.89±1.5 4.89±1.5 .052 
Social 4.19±1.7 4.64±1.6 .395 
Total 3.74±1 4.43±1.2 .090 
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Table 4.4.6 
SF12 NLIP group QOLO group p 
Mental 52.96±10.7 48.91±12.8 .403 
Physical 29.51±8.5 33.94±9.4 .284 
 
When comparing both the NLIP and QOLO groups quality of life results at baseline it 
can be seen that a significant difference did exist in the results of the Vascuqol in the 
domains of PAD symptoms and Emotion. The QOLO group identified as having 
significantly worse PAD symptoms and almost significantly poorer emotional well-
being than those in the NLIP group at baseline. No significant difference was 
identified between the two group in either domains of the SF12 questionnaire. Both 
groups did also encounter a reasonable attrition rate, and as such it should be noted 
that QOL analysis was performed on an “intention to treat” basis. 
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Chapter 5 
Discussion and Recommendations 
 
5.1 Introduction 
The final chapter of this thesis will discuss the results from the previous chapter in 
detail and identify what they have added to the body of knowledge in this field of 
study. It will also identify challenges encountered and recognise limitations of this 
study. Finally, it will identify recommendations for how this knowledge may be used 
to guide patient care as well as highlight areas requiring further investigation. 
5.2 Background 
Peripheral arterial disease is known to have a significantly high morbidity and 
mortality rate with sufferers demonstrating a significantly reduced functional capacity, 
accelerated rates of functional decline and reduction in quality of life (McDermott et 
al., 2001; Pratt et al., 2005).  
Nurse-led intervention programs for PAD provide the opportunity to combine both 
supervised exercise and risk factor modification as recommended in the ACC/AHA 
and TASC II guidelines (Hirsch et al., 2006; Norgren et al., 2007). Even so, nurse-led 
intervention programs for PAD are known to be an under-utilised resource 
(Shalhoub, Hamish, & Davies, 2009). While there have been multiple studies 
examining the optimal modality, length and level of supervision required for a PAD 
exercise program (Gardner et al., 2012; Hiatt et al., 1994), there is a paucity of 
evidence regarding nurse-led intervention programs which incorporate both 
supervised exercise and risk factor modification which have been assessed through 
multiple outcome measures over a sustained time period.  
This study sought to identify whether improvements in functional capacity and quality 
of life following participation in a nurse-led intervention program could be sustained 
over a longer-term follow up period. This not only supplements existing evidence 
regarding short-term efficacy of such programs but also the long-term benefits they 
can provide for PAD sufferers and an increasingly overburdened health system. 
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5.3 Functional Capacity 
Following the nurse-led intervention program, both claudication pain time and 
maximum walk time were significantly improved when compared to baseline 
assessment (both p<.01) which was expected and is congruent with existing 
research results directly following intervention programs (C. J. Watson et al., 2008).  
The aim of this study however, was to determine the sustainability of functional 
improvements following a nurse-led intervention program so of greater interest was 
the discovery that both treadmill and corridor test results remained significantly 
improved above baseline 9 months later, at the 12 month follow-up point (p<.05).  
It is also essential to note that only one person in the intervention program 
underwent a peripheral arterial stent within their first 12 months of participation and 
this person did not return for 12 month testing so this can be excluded as a potential 
factor in sustaining these functional improvements. 
At the final follow up (30 months) claudication pain time remained significantly 
improved compared to baseline (p<.05) however both maximum walk time and six 
minute walk were no longer significantly improved. This not only shows that people 
who took part in the nurse-led intervention program were in fact able to sustain 
significantly improved pain-free walking distance, but also given the functional 
decline expected for people with PAD (McDermott et al., 2004) it would be 
reasonable to suggest that even a lack of functional decline in this population may in 
fact be as optimal an outcome as one can expect.  
Again at the 30 month time point it must be noted that of the 5 people who had 
undergone peripheral stent or angioplasty since the 12 month follow up visit, none of 
them were able to perform the treadmill test (due to physical limitations other than 
worsening claudication). Similarly, of the 2 participants who had undergone 
peripheral arterial bypass surgery since the 12 month visit, one did not return for final 
testing. The other did return however their treadmill results were reduced and their 
six-minute walk results unchanged when compared to their baseline. This may have 
been due to remaining disease in the contralateral limb which continued to cause 
claudication, Therefore, surgical or endovascular intervention can be excluded as a 
potential contributor to the sustained improvement in claudication pain time. 
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It has been suggested in some studies that when using the  treadmill as a functional 
assessment tool, it is essential to perform a test, re-test method so as to eliminate 
unfamiliarity with equipment as a potential factor for reduced initial performance 
(Askew, Green, Hou, & Walker, 2002). This requires participants to perform a 
treadmill test and then return the following day to perform it again, with the second 
results being regarded as baseline. This was not feasible for this study as it was felt 
that participants would be unwilling to do so. The correlations which were found 
between the treadmill scores and six-minute walk at both baseline and 30 months 
(Table 4.3.4) suggests that the test, re-test method may in fact be unnecessary. Both 
CPT and MWT were found to significantly correlate to six-minute walk at baseline 
(p<.001) and even at 30 months MWT significantly correlated to six-minute walk 
(p<.05) and CPT trended towards correlating (p=.06). As it is not suggested that a 
person should test-retest when performing a corridor walk test these results suggest 
that it should not have been a factor contributing to the improvements in treadmill 
scores.  
Modelling for predictors of functional measure was difficult due to the unequal 
participant numbers at the follow up time points. Both Mean ABI and total cholesterol 
were found to be significant predictors of baseline MWT. It is not surprising that 
mean ABI would predict baseline MWT as it would be expected that people with a 
lower ABI would have a reduced MWT. This finding does however validate the 
sample group. The finding of total cholesterol as a predictor for baseline MWT was 
more of a surprising discovery. This finding validates the need for strict lipid 
management for people with PAD, not only for the reduction of cardiovascular risk 
but also for improvement of walking distance. This may in fact be a more tangible 
incentive for people with PAD than simply improvement in risk. 
 
5.4 Quality of Life 
When examining the quality of life results it is important to bear in mind that the 
QOLO (quality of life only) group cannot represent a true “control” group due to a 
lack of randomisation process. The group consisted of people who were eligible to 
participate in the program however  were unable to due to geographical distance or 
travel issues, not simply because they did not want to participate. This group also 
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identified as having significantly worse PAD symptoms at baseline. This is another 
reason why the two groups are not directly comparable and may be the reason for 
the increased number of peripheral arterial bypasses (compared to the NLIP group) 
being performed on this group during the 52 month follow up time period. 
Interestingly however, regardless of the higher rates of surgical intervention, no 
improvement was evident in any domains of either QOL assessment tool in the 
QOLO group at the 30 month follow up.    
 Taking into account the physical limitations experienced by the NLIP (nurse-led 
intervention program) group which prevented many of them from performing follow 
up treadmill testing (including severe musculoskeletal, balance issues or 
amputations) it is evident why a disease specific tool would be more accurate in this 
population. Given the extensive comorbid conditions this population are plagued 
with, the ability to discern between claudication pain and other bodily pain is 
essential. 
The SF12 being a general quality of life tool, examined only overall physical and 
mental domains. Although it did show a significant improvement in both domains 12 
months following the intervention program no further improvement were seen in 
either group at any time point. 
The disease specific quality of life tool, the Vascuqol was able to identify 
improvements at a more specific level by addressing both pain and PAD symptoms 
individually. While the NLIP group statistically improved all domains except social 
following the intervention program, the improvement in “pain” was no longer evident 
at 12 months, yet “PAD symptoms” remained significantly improved compared to 
baseline (p=.035). This is consistent with the ailments identified as preventing people 
from performing treadmill testing at 12 months and similarly at the 30 month time 
point also. 
Participants in the NLIP group also demonstrated sustained improvement (compared 
to baseline) in the domain of “emotion” at both the 12 and 30 month time points 
(p=.041 and p=.043 respectively).  
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The results from the quality of life assessments demonstrate that a nurse-led 
intervention program can lead to sustained improvement in both PAD symptoms and 
emotional wellbeing. 
 
 
5.5 What this study has added to the body of evidence 
When compared to other studies on nurse-led and non-nurse led intervention 
programs for PAD (Table 5.5.1) it can be seen that this study is of comparable 
sample size with studies of longer duration. This study provides one of the longest 
follow-up terms when compared to the existing literature and by using treadmill and 
corridor assessment, it provides “harder” endpoints than some of the studies which 
assess functional capacity using questionnaires only.  
The results of this study contribute to the evidence surrounding the efficacy of nurse-
led intervention programs for PAD and the need for greater implementation and 
access to such programs. In Queensland there are over 60 cardiac rehabilitation 
programs, while there are still only a handful of PAD programs Australia wide. 
Evidence from this study suggests that nurse-led intervention program can provide 
sustained improvements for people suffering from PAD and such programs should 
not necessarily be seen as an alternative to surgical intervention, but more an 
essential part of the long-term management of this chronic disease, which can 
complement any required surgical or endovascular intervention. 
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Table 5.5.1 
 
^= not statistically significant       **=p<0.001        °=p value not stated      QOL=Quality of Life assessment 
First 
Author 
Year Study type Participants (n) Intervention Follow-
up,  
Months 
Functional 
Assessment 
Method  
Additional 
Outcome 
 Measures 
Results 
Nurse-led Programs 
Braun  1999 Retrospective 
analysis 
22 12 week supervised Exercise  + 
risk factor modification education 
24 
 
 
Treadmill Test  Increased ° 
 
 
Spronk 
 
2003 Prospective 
study 
104 
 
 
8-16 week Home-based exercise 
program + risk factor modification 
4 Corridor walking 
assessment 
 Increased ° 
Sillesen 2007 Prospective 
cohort study 
693 
 
12 Months=331 
Exercise advice + risk factor 
modification 
12 
 
 
 
Questionnaire  
 
Risk Factors  
(mean TC, LDL, BP) 
Increased** 
 
Improved** 
 
 
Hatfield  2008 Prospective 
study 
78 Exercise advice + Structured risk 
factor modification 
3  Framingham 
Risk 
Improved**  
Simmons 2013 Quality 
improvement 
project 
17 Home-based exercise  1 Questionnaire  Increased 
frequency of  
exercise^ 
McLennan 2014 Prospective 
Study 
Group 1      56 
 
 
Group 2      23 
12 Week supervised exercise 
program & risk factor modification 
education 
Exercise advice 
30 Treadmill & 
Six minute walk 
 
Not avail 
QOL  
 
 
QOL 
Increased 
 
Improved QOL 
 
Non-Nurse-led Programs 
Franz 2010 Prospective 
study 
47 12 week supervised exercise 
program + risk factor modification 
3 Treadmill Test & 
12 Minute Walk 
 
 
Risk Factors 
(Mean BMI, BP, 
Lipids)  
Increased** 
 
Improved^  
 
 
Fakhry  2011 Comparative 
longitudinal 
cohort study 
Group 1      142 
 
 
Group 2        75 
 
24 Week structured home 
exercise program 
 
24 Week supervised exercise 
program 
12 
 
 
Treadmill 
 
 
Treadmill 
 
QOL 
 
 
QOL 
Increased**  
Increased**  
 
Increased**   
Increased**  
Guidon 2013 Randomised 
control trial 
Group 1       17 
 
 
Group 2       12 
12 week supervised exercise 
program  
 
Exercise advice 
12 Questionnaire 
 
 
Questionnaire 
 
QOL 
  
 
QOL 
Increased^ 
Increased^  
 
Decreased 
Decreased 
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5.6 Research Challenges  
Recruitment can prove challenging for any interventional study in PAD (C. J. Watson 
et al., 2008) and this study did undergo initial difficulties in recruitment. The original 
TEMPLATE trial excluded people who had undergone peripheral arterial bypass, 
stent or angioplasty within the past 12 months. However, this did not allow for the 
fact that people still may have been suffering from claudication due to disease in the 
contralateral limb, or even more distal disease in the ipsilateral limb. In a revision of 
the protocol after 9 months due to  lower-than-expected recruitment numbers this 
exclusion criteria was removed, and the only inclusion criteria became symptomatic 
PAD as determined by Edinburgh Claudication Questionnaire (Leng & Fowkes, 
1992). This improved recruitment numbers and is also an important factor to be 
taken into consideration when coordinating a nurse-led PAD program.  Peripheral 
arterial bypass, stent or angioplasty are performed for management of symptoms or 
for limb salvage but they obviously cannot cure the systemic disease process of 
PAD. Therefore, exercise and risk factor modification must remain an ongoing part of 
the chronic disease management for PAD, regardless of symptoms.  
Another obstacle encountered not only for recruitment but the general management 
of people with PAD, is the need to wait for review from a member of the Vascular 
Surgical team before a referral to a nurse-led intervention program can occur. In the 
public hospital setting where this study was conducted it is evident that people have 
been symptomatic of PAD for sometimes years before being seen as a non-urgent 
outpatient. This delay is not only due to public hospital outpatient waiting lists, but 
also the time it has taken for the patient to mention their symptoms to their primary 
care physician who can then make referrals for vascular investigations and reviews. 
When PAD is known to have a 15-30% 5-year mortality rate, this is time that really 
cannot afford to be lost (Hirsch et al., 2006). Community awareness of PAD, its 
signs, symptoms and progression as well as greater community screening are things 
that could help to reduce this wait. Access to nurse-led intervention programs from 
the primary care setting could also alleviate some burden from the extensive public 
hospital outpatient waiting lists. 
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5.7 Limitations 
There are some limitations to this study which we have identified. The lack of a true 
control group through a randomisation process is certainly a limitation. As the current 
guidelines (ACC/AHA and TASCII) recommend supervised exercise as optimal initial 
treatment for PAD it was felt that to deny willing participants access to such a 
program would be unethical (Hirsch et al., 2006; Norgren et al., 2007).  
Another limitation is the lack of physical and functional assessment form the quality 
of life only group. This was simply not feasible as the people in this group were not 
able to attend the nurse-led intervention program due to geographical distance from 
the hospital and some had no knowledge of when or if they might be returning to the 
hospital for further appointments. 
It is also disappointing that not all participants in the intervention program group were 
able to perform a graded treadmill test at follow up visits. This is due to the nature of 
the progressive treadmill test and its set speed and incline. It would have posed a 
significant safety threat for participants of declining physical function to have 
attempted it and thus they were only able to perform corridor walking test (six minute 
walk). People with worsening claudication were not omitted from treadmill testing, 
only those with severe balance, musculoskeletal complaints or amputations. 
5.8 Conclusion 
Peripheral arterial disease, as an atherothrombotic disease, contributes to the 
number one killer of all Australians (Ademi et al., 2010). While existing guidelines 
recommend supervised exercise and strict risk factor reduction for the management 
of PAD, nurse-led intervention programs which provide the opportunity to do both 
remain scarce and underutilised in Australia. 
This study demonstrates that nurse-led intervention programs for people with 
peripheral arterial disease can lead to sustained improvements in pain-free walking 
distance, PAD symptoms and emotional well-being.  
Greater community awareness of PAD and creation of more programs which are 
accessible from the primary care setting could further improve outcomes for people 
with PAD and reduce hospital outpatient waiting lists.  Further investigation is 
required to identify if increasing access to programs and community education could 
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lead to a reduction in the high mortality and morbidity rates associated with this 
condition. 
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